According to the research report published by Market IntelliX, the global market for Anticonvulsant Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Anticonvulsant Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Anticonvulsant Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Anxiety has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Anticonvulsant Drug include GlaxoSmithKline Plc, Astellas Pharma Technologies, Valeant Pharmaceuticals N.A, Bausch Health Companies, Watson Laboratories, Abbott Laboratories, Teva Pharmaceutical Industries, Johnson & Johnson and Novartis AG, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

The anticonvulsant drug is a type of drug that is used to prevent or treat seizures or convulsions by controlling abnormal electrical activity in the brain.

This report aims to provide a comprehensive study of the global market for Anticonvulsant Drug. Report Highlights:

(1) Global Anticonvulsant Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Anticonvulsant Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Anticonvulsant Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Anticonvulsant Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Anticonvulsant Drug segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Anticonvulsant Drug, capacity, production and trends.

(7) Anticonvulsant Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)

Barbiturate

Benzodiazepine

Carbamate Anticonvulsants

Carbonic Anhydrase Inhibitor

Dibenzazepine

Triazine

Market segment by application, can be divided into

Anxiety

Bipolar Disorder

Borderline Personality Disorder

Epilepsy

Fibromyalgia

Migraine

Neuropathic Pain

Others

Market segment by players, this report covers

GlaxoSmithKline Plc

Astellas Pharma Technologies

Valeant Pharmaceuticals N.A

Bausch Health Companies

Watson Laboratories

Abbott Laboratories

Teva Pharmaceutical Industries

Johnson & Johnson

Novartis AG

Pfizer

Shire Plc

UCB Group

Huazhong Pharmaceutical Company Limited

Changzhou Siyao Pharmaceutical

Shandong Xinyi Pharmaceutical

Table 1. Anticonvulsant Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Anticonvulsant Drug Market Restraints

Table 3. Anticonvulsant Drug Market Trends

Table 4. Anticonvulsant Drug Industry Policy

Table 5. Global Anticonvulsant Drug Revenue by Company, 2018-2023, US$ million

Table 6. Global Anticonvulsant Drug Revenue Market Share by Company, 2018-2023

Table 7. Global Anticonvulsant Drug Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Anticonvulsant Drug Sales Volume Market Share by Company, 2018-2023

Table 9. Global Anticonvulsant Drug Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Anticonvulsant Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Anticonvulsant Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Anticonvulsant Drug Manufacturers Product Type

Table 13. China Anticonvulsant Drug Revenue by Company, 2018-2023, US$ million

Table 14. China Anticonvulsant Drug Revenue Market Share by Company, 2018-2023

Table 15. China Anticonvulsant Drug Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Anticonvulsant Drug Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Anticonvulsant Drug Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Anticonvulsant Drug Import & Export Trends

Table 19. Main Sources of China Anticonvulsant Drug Import

Table 20. Export Destination of China Anticonvulsant Drug

Table 21. Global Headquarters and Manufacturing Base of Anticonvulsant Drug Manufacturers

Table 22. Global Major Manufacturers, Anticonvulsant Drug Capacity Expansion and Future Plans

Table 23. Global Anticonvulsant Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Anticonvulsant Drug Production by Region, 2018-2023, (K Units)

Table 25. Global Anticonvulsant Drug Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Anticonvulsant Drug Upstream (Raw Materials)

Table 27. Global Anticonvulsant Drug Typical Customers

Table 28. Anticonvulsant Drug Typical Distributors

Table 29. By Type, Global Anticonvulsant Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Anticonvulsant Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Anticonvulsant Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Anticonvulsant Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Anticonvulsant Drug Revenue Market Share, 2018-2029

Table 37. By Country, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029

Table 39. GlaxoSmithKline Plc Company Information, Head Office, Market Area and Industry Position

Table 40. GlaxoSmithKline Plc Anticonvulsant Drug Models, Specifications and Application

Table 41. GlaxoSmithKline Plc Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. GlaxoSmithKline Plc Company Profile and Main Business

Table 43. GlaxoSmithKline Plc Recent Developments

Table 44. Astellas Pharma Technologies Company Information, Head Office, Market Area and Industry Position

Table 45. Astellas Pharma Technologies Anticonvulsant Drug Models, Specifications and Application

Table 46. Astellas Pharma Technologies Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Astellas Pharma Technologies Company Profile and Main Business

Table 48. Astellas Pharma Technologies Recent Developments

Table 49. Valeant Pharmaceuticals N.A Company Information, Head Office, Market Area and Industry Position

Table 50. Valeant Pharmaceuticals N.A Anticonvulsant Drug Models, Specifications and Application

Table 51. Valeant Pharmaceuticals N.A Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Valeant Pharmaceuticals N.A Company Profile and Main Business

Table 53. Valeant Pharmaceuticals N.A Recent Developments

Table 54. Bausch Health Companies Company Information, Head Office, Market Area and Industry Position

Table 55. Bausch Health Companies Anticonvulsant Drug Models, Specifications and Application

Table 56. Bausch Health Companies Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Bausch Health Companies Company Profile and Main Business

Table 58. Bausch Health Companies Recent Developments

Table 59. Watson Laboratories Company Information, Head Office, Market Area and Industry Position

Table 60. Watson Laboratories Anticonvulsant Drug Models, Specifications and Application

Table 61. Watson Laboratories Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Watson Laboratories Company Profile and Main Business

Table 63. Watson Laboratories Recent Developments

Table 64. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 65. Abbott Laboratories Anticonvulsant Drug Models, Specifications and Application

Table 66. Abbott Laboratories Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Abbott Laboratories Company Profile and Main Business

Table 68. Abbott Laboratories Recent Developments

Table 69. Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position

Table 70. Teva Pharmaceutical Industries Anticonvulsant Drug Models, Specifications and Application

Table 71. Teva Pharmaceutical Industries Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Teva Pharmaceutical Industries Company Profile and Main Business

Table 73. Teva Pharmaceutical Industries Recent Developments

Table 74. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 75. Johnson & Johnson Anticonvulsant Drug Models, Specifications and Application

Table 76. Johnson & Johnson Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Johnson & Johnson Company Profile and Main Business

Table 78. Johnson & Johnson Recent Developments

Table 79. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 80. Novartis AG Anticonvulsant Drug Models, Specifications and Application

Table 81. Novartis AG Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Novartis AG Company Profile and Main Business

Table 83. Novartis AG Recent Developments

Table 84. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 85. Pfizer Anticonvulsant Drug Models, Specifications and Application

Table 86. Pfizer Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Pfizer Company Profile and Main Business

Table 88. Pfizer Recent Developments

Table 89. Shire Plc Company Information, Head Office, Market Area and Industry Position

Table 90. Shire Plc Anticonvulsant Drug Models, Specifications and Application

Table 91. Shire Plc Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Shire Plc Company Profile and Main Business

Table 93. Shire Plc Recent Developments

Table 94. UCB Group Company Information, Head Office, Market Area and Industry Position

Table 95. UCB Group Anticonvulsant Drug Models, Specifications and Application

Table 96. UCB Group Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. UCB Group Company Profile and Main Business

Table 98. UCB Group Recent Developments

Table 99. Huazhong Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position

Table 100. Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Models, Specifications and Application

Table 101. Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Huazhong Pharmaceutical Company Limited Company Profile and Main Business

Table 103. Huazhong Pharmaceutical Company Limited Recent Developments

Table 104. Changzhou Siyao Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 105. Changzhou Siyao Pharmaceutical Anticonvulsant Drug Models, Specifications and Application

Table 106. Changzhou Siyao Pharmaceutical Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Changzhou Siyao Pharmaceutical Company Profile and Main Business

Table 108. Changzhou Siyao Pharmaceutical Recent Developments

Table 109. Shandong Xinyi Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 110. Shandong Xinyi Pharmaceutical Anticonvulsant Drug Models, Specifications and Application

Table 111. Shandong Xinyi Pharmaceutical Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Shandong Xinyi Pharmaceutical Company Profile and Main Business

Table 113. Shandong Xinyi Pharmaceutical Recent Developments

List of Figure

Figure 1. Anticonvulsant Drug Picture

Figure 2. By Revenue, Global Anticonvulsant Drug Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Anticonvulsant Drug Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Anticonvulsant Drug Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Anticonvulsant Drug Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Anticonvulsant Drug Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Anticonvulsant Drug Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Anticonvulsant Drug Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Anticonvulsant Drug Share of Global Market, 2018-2029

Figure 10. Global Anticonvulsant Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Anticonvulsant Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Anticonvulsant Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Anticonvulsant Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Anticonvulsant Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Anticonvulsant Drug Domestic VS Export, 2022

Figure 16. Global Anticonvulsant Drug Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Anticonvulsant Drug Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Anticonvulsant Drug Production Market Share & Forecast by Region, 2018-2029

Figure 19. Anticonvulsant Drug Industry Chain

Figure 20. Anticonvulsant Drug Procurement Model

Figure 21. Anticonvulsant Drug Sales Model

Figure 22. Anticonvulsant Drug Sales Channels, Direct Sales and Distribution

Figure 23. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)

Figure 24. Barbiturate

Figure 25. Benzodiazepine

Figure 26. Carbamate Anticonvulsants

Figure 27. Carbonic Anhydrase Inhibitor

Figure 28. Dibenzazepine

Figure 29. Triazine

Figure 30. By Type, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million

Figure 31. By Type, Global Anticonvulsant Drug Revenue Market Share, 2018-2029

Figure 32. By Type, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 33. By Type, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029

Figure 34. By Type, Global Anticonvulsant Drug Price, 2018-2029, (US$/Unit)

Figure 35. Anxiety

Figure 36. Bipolar Disorder

Figure 37. Borderline Personality Disorder

Figure 38. Epilepsy

Figure 39. Fibromyalgia

Figure 40. Migraine

Figure 41. Neuropathic Pain

Figure 42. Others

Figure 43. By Application, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million

Figure 44. By Application, Global Anticonvulsant Drug Revenue Market Share, 2018-2029

Figure 45. By Application, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 46. By Application, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029

Figure 47. By Application, Global Anticonvulsant Drug Price, 2018-2029, (US$/Unit)

Figure 48. By Region, Global Anticonvulsant Drug Revenue Market Share, 2018-2029

Figure 49. By Region, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029

Figure 50. North America Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. By Country, North America Anticonvulsant Drug Revenue Market Share, 2022

Figure 52. Europe Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 53. By Country, Europe Anticonvulsant Drug Revenue Market Share, 2022

Figure 54. Asia Pacific Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 55. By Country/Region, Asia Pacific Anticonvulsant Drug Revenue Market Share, 2022

Figure 56. South America Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 57. By Country, South America Anticonvulsant Drug Revenue Market Share, 2022

Figure 58. Middle East & Africa Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 59. U.S. Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 60. By Company, U.S. Anticonvulsant Drug Market Share, 2022

Figure 61. By Type, U.S. Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, U.S. Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 63. Europe Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 64. By Company, Europe Anticonvulsant Drug Market Share, 2022

Figure 65. By Type, Europe Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Europe Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 67. China Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 68. By Company, China Anticonvulsant Drug Market Share, 2022

Figure 69. By Type, China Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, China Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 71. Japan Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 72. By Company, Japan Anticonvulsant Drug Market Share, 2022

Figure 73. By Type, Japan Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Japan Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 75. South Korea Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 76. By Company, South Korea Anticonvulsant Drug Market Share, 2022

Figure 77. By Type, South Korea Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, South Korea Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 79. Southeast Asia Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 80. By Company, Southeast Asia Anticonvulsant Drug Market Share, 2022

Figure 81. By Type, Southeast Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Southeast Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 83. India Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 84. By Company, India Anticonvulsant Drug Market Share, 2022

Figure 85. By Type, India Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 86. By Application, India Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 87. Middle East & Asia Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)

Figure 88. By Company, Middle East & Asia Anticonvulsant Drug Market Share, 2022

Figure 89. By Type, Middle East & Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 90. By Application, Middle East & Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029

Figure 91. Research Methodology

Figure 92. Breakdown of Primary Interviews

Figure 93. Bottom-up Approaches

Figure 94. Top-down Approaches